Doctor Michel Farnier
University of Bourgogne Franche Comte, Dijon (France)
Change of paradigm in dyslipidemia management
Event: ESC Congress 2022
Topic: Lipids
Session type: Satellite Symposium
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition & cardiovascular outcomes: review of lipid targets and treatment strategies (EBAC Accredited)
Event: ESC Congress 2017
Topic: Drug therapy
Session type: Satellite Symposium
ESC 365 is supported by
